{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:52:12Z","timestamp":1753883532933,"version":"3.41.2"},"reference-count":30,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Non\u2013small cell lung cancer (NSCLC) is often diagnosed at late stages, leading to escalated treatment expenses. This study aimed to elucidate the costs of lung cancer treatment in a private health care setting in Brazil.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>We conducted a retrospective cohort study, regarding costs, survival, and quality of care of stage IV NSCLC in a private health company in Brazil.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              A total of 819 individuals were included, with median age 64.9 years. With a 1-year follow-up, patients had a median of four hospital admissions, with a median length of stay in of 6.2 days. Survival rates were higher for patients treated with targeted therapy (hazard ratio [HR], 0.38 [95% CI, 0.25 to 0.56]), immunotherapy (HR, 0.52 [95% CI, 0.40 to 0.68]), or both treatments sequentially (0.41 [95% CI, 0.25 to 0.68]). Patients submitted to sequentially targeted therapy and immunotherapy had the higher total costs (mean, $172,828 USD) compared with patients treated with immunotherapy (mean, $138,125 USD), targeted therapy (mean, $117,068 USD), and only chemotherapy (mean, $47,625 USD). As expected, longer survival was translated into more third-line therapy (\n              <jats:italic>P<\/jats:italic>\n              &lt; .001), and higher mean costs with cancer-related hospital admissions ($24,554 USD chemo, $31,835 USD immuno, $28,228 USD targeted, and $35,494 USD for both therapies). However, costs did not increase in proportion to the survival benefit. Despite longer survival, patients undergoing targeted therapy or immunotherapy had median number of hospital admissions and length of stay similar to those who underwent chemotherapy alone.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Higher survival rates and costs were found for patients exposed to modern treatments for advanced NSCLC. Cost-effectiveness thresholds definitions are warranted for managing costs, particularly in developing countries.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/go-24-00253","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T20:05:37Z","timestamp":1743192337000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Data on Metastatic Lung Cancer: Cost Analyses in Brazil From a Private Insurance Company's Perspective"],"prefix":"10.1200","author":[{"given":"Rodrigo Afonso da Silva","family":"Sardenberg","sequence":"first","affiliation":[{"name":"Instituto Americas, S\u00e3o Paulo, Brazil"},{"name":"Centro de Pesquisa Internacional do Hospital Alem\u00e3o Oswaldo Cruz, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9552-6977","authenticated-orcid":true,"given":"Mariana Ribeiro","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Instituto Americas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6452-2974","authenticated-orcid":true,"given":"Cinthia Leite Frizzera Borges","family":"Bognar","sequence":"additional","affiliation":[{"name":"Instituto Americas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Braga","family":"Gondim Teixeira","sequence":"additional","affiliation":[{"name":"Instituto Americas, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3256-9694","authenticated-orcid":true,"given":"Rodrigo","family":"de Carvalho Moreira","sequence":"additional","affiliation":[{"name":"Instituto Americas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5708-2308","authenticated-orcid":true,"given":"Henry","family":"Sznejder","sequence":"additional","affiliation":[{"name":"Instituto Americas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riad Naim","family":"Younes","sequence":"additional","affiliation":[{"name":"Centro de Pesquisa Internacional do Hospital Alem\u00e3o Oswaldo Cruz, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1590\/s1806-37562017000000135"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00228"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.3747\/co.27.6049"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.04.005"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.03.012"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.60"},{"key":"e_1_3_5_9_2","first-page":"100336","article-title":"The burden of cancer in Latin America and the Caribbean: Time for planning a better cancer control","volume":"13","author":"Mohar-Betancourt A","year":"2022","unstructured":"Mohar-Betancourt A: The burden of cancer in Latin America and the Caribbean: Time for planning a better cancer control. Lancet Reg Health Am 13:100336, 2022","journal-title":"Lancet Reg Health Am"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2020.05.008"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-2933-0"},{"key":"e_1_3_5_12_2","first-page":"86","article-title":"Padr\u00f5es de tratamento, uso de recursos e custo do c\u00e2ncer de pulm\u00e3o de n\u00e3o pequenas c\u00e9lulas avan\u00e7ado em institui\u00e7\u00f5es brasileiras privadas","volume":"10","author":"Baldotto C","year":"2018","unstructured":"Baldotto C, Julian G, Mascarenhas E, et al: Padr\u00f5es de tratamento, uso de recursos e custo do c\u00e2ncer de pulm\u00e3o de n\u00e3o pequenas c\u00e9lulas avan\u00e7ado em institui\u00e7\u00f5es brasileiras privadas. J Bras Econ Sa\u00fade 10:86-106, 2018","journal-title":"J Bras Econ Sa\u00fade"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801005"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603887"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23058"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00472.x"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","unstructured":"Howlander N Forjaz G Mooradian M et al: The effect of advances in lung-cancer treatment on population mortality. N Engl J Med 383:640-649 2020","DOI":"10.1056\/NEJMoa1916623"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"e_1_3_5_21_2","first-page":"565","article-title":"Metastatic non-small cell lung cancer: Costs associated with disease progression","volume":"14","author":"Fox KM","year":"2008","unstructured":"Fox KM, Brooks JM, Kim J: Metastatic non-small cell lung cancer: Costs associated with disease progression. Am J Manag Care 14:565-571, 2008","journal-title":"Am J Manag Care"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31643"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2013.001322"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.2232"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.6620"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.e18838"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.11005"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn103"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-11-305"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.823618"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.1_suppl.21S"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-24-00253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T20:05:57Z","timestamp":1743192357000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-24-00253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1200\/GO-24-00253"],"URL":"https:\/\/doi.org\/10.1200\/go-24-00253","relation":{},"ISSN":["2687-8941"],"issn-type":[{"type":"electronic","value":"2687-8941"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400253"}}